1. Home
  2. MATH vs BDSX Comparison

MATH vs BDSX Comparison

Compare MATH & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

HOLD

Current Price

$2.84

Market Cap

145.4M

Sector

Finance

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$8.20

Market Cap

53.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATH
BDSX
Founded
2015
2005
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
145.4M
53.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MATH
BDSX
Price
$2.84
$8.20
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
105.0K
65.3K
Earning Date
12-05-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.41
N/A
Revenue
$44,567,257.00
$80,173,000.00
Revenue This Year
N/A
$20.75
Revenue Next Year
N/A
$25.05
P/E Ratio
$6.98
N/A
Revenue Growth
165.86
22.29
52 Week Low
$0.99
$3.44
52 Week High
$4.17
$32.20

Technical Indicators

Market Signals
Indicator
MATH
BDSX
Relative Strength Index (RSI) 47.09 54.92
Support Level $2.84 $7.24
Resistance Level $3.12 $8.38
Average True Range (ATR) 0.20 0.58
MACD 0.01 0.01
Stochastic Oscillator 52.90 74.07

Price Performance

Historical Comparison
MATH
BDSX

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: